Encompass Health prices private offering of additional 5.875% senior notes due 2034

Rhea-AI Summary

Encompass Health (NYSE:EHC) priced a private offering of an additional $100 million aggregate principal amount of its 5.875% senior notes due 2034 at 98.75% of principal. The Additional Notes reopen the 2034 series issued in May 2026, share the same terms, and pay interest semiannually on June 1 and Dec. 1, starting Dec. 1, 2026.

The notes will be senior unsecured obligations, jointly and severally guaranteed by existing and future subsidiary guarantors under the company's credit agreement and other capital markets debt. Encompass Health expects to close the offering on August 13, 2026 and intends to use net proceeds, along with cash on hand, to repay outstanding amounts under its senior secured revolving credit facility. The offering is limited to qualified institutional buyers under Rule 144A and certain non-U.S. investors under Regulation S and will not be registered under the Securities Act.

Positive

• $100 million additional senior notes due 2034 priced and allocated
• Debt maturity extended to 2034 via reopening of existing 5.875% notes
• Proceeds and cash on hand earmarked to repay senior secured revolving credit facility
• Notes guaranteed on a senior unsecured basis by existing and future subsidiary guarantors

Negative

• Additional $100 million in senior notes increases total debt outstanding
• Notes priced at 98.75% of principal, reflecting issuance at a discount
• Private offering under Rule 144A/Reg S means notes are not registered under the Securities Act

News Explained

The Encompass Health offering is priced but not yet closed; because it issues senior notes rather than additional shares, its disclosed mechanics add a note obligation intended to repay the revolving facility without changing existing holders’ percentage ownership through share issuance.

Market Context

Tag-specific history for EHC's private offerings showed an average -0.4% 24-hour move. That record p...

Analysis

Tag-specific history for EHC's private offerings showed an average -0.4% 24-hour move. That record places this debt refinancing in a cautious financing context; closing and credit-facility repayment are the key follow-through items.

Key Figures

Additional principal: $100 million Interest rate: 5.875% Maturity: 2034 +3 more

6 metrics

Additional principal $100 million Additional 5.875% senior notes due 2034

Interest rate 5.875% Additional senior notes due 2034

Maturity 2034 Additional senior notes

Offering price 98.75% of principal amount Pricing of the Additional Notes

Interest payment dates June 1 and Dec. 1 Semiannual payments beginning Dec. 1, 2026

Expected closing August 13, 2026 Subject to customary closing conditions

Previous Private placement,offering Reports

2 past events · Latest: May 14 (Negative)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
May 14	Senior notes offering	Negative	-0.6%	Priced $500 million senior notes to refinance debt and pay related fees.
May 14	Senior notes offering	Negative	-0.2%	Launched $500 million senior notes to redeem 2028 notes and repay revolver.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

EHC's two tag-specific private offering events were followed by negative 24-hour reactions.

Key Terms

rule 144a, regulation s, senior unsecured basis, senior notes

4 terms

rule 144a regulatory

"pursuant to Rule 144A under the Securities Act of 1933"

Rule 144A is a regulation that makes it easier for companies to sell private bonds to large investors without going through all the usual rules that apply to public sales. It matters because it helps companies raise money more quickly and privately, often attracting big investors looking for special deals.

regulation s regulatory

"outside the United States pursuant to Regulation S under the Securities Act"

Regulation S is a set of rules that allows companies to sell securities (like shares or bonds) to investors outside the United States without having to follow all U.S. securities laws. It matters because it makes it easier for companies to raise money from international investors while still complying with U.S. regulations.

senior unsecured basis financial

"guaranteed on a senior unsecured basis by all of its existing and future subsidiaries"

Debt issued on a senior unsecured basis is borrowing that ranks ahead of other unsecured or subordinated claims for repayment but is not backed by specific collateral. For investors it signals priority in the lender hierarchy—similar to being first in line at a buffet among unsecured creditors—and typically affects expected recovery in default and the interest rate the issuer must pay.

senior notes financial

"additional $100 million in aggregate principal amount of its 5.875% senior notes"

Senior notes are a type of loan that a company borrows from investors, promising to pay it back with interest. They are called "senior" because in case the company faces financial trouble, these lenders are paid back before others. This makes senior notes safer for investors compared to other types of loans or bonds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BIRMINGHAM, Ala., Aug. 10, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced the pricing of a private offering of an additional $100 million in aggregate principal amount of its 5.875% senior notes due 2034 (the "Additional Notes") at a price of 98.75% of the principal amount thereof. The Additional Notes will constitute a reopening of the Company's 5.875% senior notes maturing in 2034 originally issued in May 2026 (the "Existing Notes") and will be treated as the same class as, and will have the same terms (other than the date of issuance and the offering price) as, the Existing Notes. The Company will pay interest on the Additional Notes semiannually in arrears on June 1 and Dec. 1 of each year, beginning on Dec. 1, 2026. The Additional Notes will be jointly and severally guaranteed on a senior unsecured basis by all of its existing and future subsidiaries that guarantee borrowings under the Company's credit agreement and other capital markets debt. This offering is expected to close on August 13, 2026, subject to customary closing conditions.

The Company intends to use the net proceeds from the offering of the Additional Notes, together with cash on hand, to repay outstanding amounts under the Company's senior secured revolving credit facility.

The Additional Notes have been offered in the United States only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain non-U.S. persons in transactions outside the United States pursuant to Regulation S under the Securities Act. The offer and any sale of the Additional Notes and the related guarantees have not been and will not be registered under the Securities Act or any state securities laws, and the Additional Notes may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws.

This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security and does not constitute an offer, solicitation or sale of any security in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Encompass Health 
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 176 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized by Newsweek as America's Most Awarded Leader in Inpatient Rehabilitation and is ranked among Fortune's World's Most Admired Companies™ and Forbes' America's Best Companies. It is also recognized by Becker's Healthcare and Modern Healthcare as a top healthcare employer.  For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.

From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health.

Forward-looking statements
Statements contained in this press release which are not historical facts, such as the completion of the private offering of the Additional Notes and the use of proceeds from the offering, are forward-looking statements. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Encompass Health include, but are not limited to, Encompass Health's ability to complete the offering of the Additional Notes; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; a significant disruption in the capital markets or economy; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including its Form 10-K for the year ended Dec. 31, 2025 and Forms 10-Q for the quarters ended March 31, 2026 and June 30, 2026.

Media contact:
Polly Manuel | 205-970-5912
Media@encompasshealth.com

Investor relations contact:
Mark Miller | 205-970-5860
Mark.Miller@encompasshealth.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-prices-private-offering-of-additional-5-875-senior-notes-due-2034--302847454.html

SOURCE Encompass Health Corp.

FAQ

What did Encompass Health (EHC) announce about its 5.875% senior notes due 2034 on August 10, 2026?

Encompass Health announced pricing of an additional $100 million of its 5.875% senior notes due 2034. According to Encompass Health, these Additional Notes reopen the existing 2034 series and will carry the same terms, other than issuance date and offering price.

What is the interest rate and pricing for Encompass Health’s new 2034 senior notes (EHC)?

The Additional Notes carry a fixed coupon of 5.875% and were priced at 98.75% of principal. According to Encompass Health, interest will be paid semiannually in arrears on June 1 and December 1 each year, starting December 1, 2026.

How will Encompass Health (EHC) use the $100 million raised from the Additional Notes due 2034?

Encompass Health intends to use the net proceeds, together with cash on hand, to repay outstanding amounts under its senior secured revolving credit facility. According to Encompass Health, this redeploys borrowing from secured bank debt into longer-term senior notes.

When is the expected closing date of Encompass Health’s private offering of Additional Notes (EHC)?

The offering is expected to close on August 13, 2026, subject to customary closing conditions. According to Encompass Health, closing will finalize issuance of the Additional Notes, which will then form part of the existing 5.875% senior notes due 2034.

Who guarantees Encompass Health’s new 5.875% senior notes due 2034 (EHC)?

The Additional Notes will be jointly and severally guaranteed on a senior unsecured basis by all existing and future subsidiaries that guarantee borrowings under the company’s credit agreement and other capital markets debt, according to Encompass Health, aligning guarantees with its broader debt structure.

Who can buy Encompass Health’s Additional Notes due 2034 and are they registered (EHC)?

The Additional Notes are offered privately to qualified institutional buyers under Rule 144A and certain non-U.S. persons under Regulation S. According to Encompass Health, the notes and guarantees are not registered under the Securities Act or state securities laws.

Are Encompass Health’s new 2034 senior notes the same as its existing 2034 notes (EHC)?

Yes, the Additional Notes constitute a reopening of the existing 5.875% senior notes maturing in 2034. According to Encompass Health, they will be treated as the same class and have the same terms, except for issuance date and offering price.